DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Laninamivir is an investigational drug.
There have been 4 clinical trials for Laninamivir. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2013.
The most common disease conditions in clinical trials are Influenza, Human, Asthma, and [disabled in preview]. The leading clinical trial sponsors are Biota Scientific Management Pty Ltd, Department of Health and Human Services, and National Institute of Allergy and Infectious Diseases (NIAID).
There are one hundred and fifty-four US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Laninamivir
|Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza||Department of Health and Human Services||Phase 1/Phase 2|
|Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza||Biota Scientific Management Pty Ltd||Phase 1/Phase 2|
|Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma||Department of Health and Human Services||Phase 1|
Top disease conditions for Laninamivir
Top clinical trial sponsors for Laninamivir
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Laninamivir||⤷ Try it Free||RSV G protein specific antibodies||AIMM THERAPEUTICS B.V. (Amsterdam, NL)||⤷ Try it Free|
|Laninamivir||⤷ Try it Free||Methods and compositions for inhibition of polymerase||BioCryst Pharmaceuticals, Inc. (Durham, NC)||⤷ Try it Free|
|Laninamivir||⤷ Try it Free||Synergistic antiviral composition and use thereof||MARINOMED BIOTECHNOLOGIE GmbH (Vienna, AT)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Laninamivir||European Patent Office||EP2780366||2031-11-17||⤷ Try it Free|
|Laninamivir||World Intellectual Property Organization (WIPO)||WO2013095091||2031-11-17||⤷ Try it Free|
|Laninamivir||Australia||AU2011315902||2030-10-15||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|